RNAi targeting heparin cofactor II promotes hemostasis in hemophilia A

Hemophilia A is a hemorrhagic disease due to congenital deficiencies of coagulation factor VIII (FVIII). Studies show that hemophilia patients with anticoagulant deficiency present less severe hemorrhagic phenotypes. We aimed to find a new therapeutic option for hemophilia patients by RNA interferen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wen-yi, Zhu, Ruiqi, Zhang, Zhen, Lu, Xuan, Wang, Huafang, He, Wenjuan, Hu, Yu, Tang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093307/
https://www.ncbi.nlm.nih.gov/pubmed/33996250
http://dx.doi.org/10.1016/j.omtn.2021.03.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093307/
https://www.ncbi.nlm.nih.gov/pubmed/33996250
http://dx.doi.org/10.1016/j.omtn.2021.03.022

Ejemplares similares